Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 May;109(5):879-887.
doi: 10.1016/j.fertnstert.2018.01.029.

Major depression, antidepressant use, and male and female fertility

Collaborators, Affiliations
Randomized Controlled Trial

Major depression, antidepressant use, and male and female fertility

Emily A Evans-Hoeker et al. Fertil Steril. 2018 May.

Abstract

Objective: To determine if maternal major depression (MD), antidepressant use, or paternal MD are associated with pregnancy outcomes after non-IVF fertility treatments.

Design: Cohort study.

Setting: Clinics.

Patient(s): Participants in two randomized trials: PPCOS II (clomiphene citrate versus letrozole for polycystic ovary syndrome), and AMIGOS (gonadotropins versus clomiphene citrate versus letrozole for unexplained infertility).

Intervention(s): Female and male partners completed the Patient Health Questionnaire (PHQ-9). Female medication use was collected. PHQ-9 score ≥10 was used to define currently active MD.

Main outcome measure(s): Primary outcome: live birth.

Secondary outcomes: pregnancy, first-trimester miscarriage. Poisson regression models were used to determine relative risks after adjusting for age, race, income, months trying to conceive, smoking, and study (PPCOS II versus AMIGOS).

Result(s): Data for 1,650 women and 1,608 men were included. Among women not using an antidepressant, the presence of currently active MD was not associated with poorer fertility outcomes (live birth, miscarriage), but rather was associated with a slightly increased likelihood of pregnancy. Maternal antidepressant use (n = 90) was associated with increased risk of miscarriage, and male partners with currently active MD were less likely to achieve conception.

Conclusion(s): Currently active MD in the female partner does not negatively affect non-IVF treatment outcomes; however, currently active MD in the male partner may lower the likelihood of pregnancy. Maternal antidepressant use is associated with first-trimester pregnancy loss, which may depend upon the type of antidepressant.

Clinical trial registration numbers: NCT00719186 and NCT01044862.

Keywords: Infertility; antidepressant; depression.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The first author, Emily Evans-Hoeker MD, has no conflicts of interest or disclosures. Please see conflict of interest forms for remaining authors.

Comment in

References

    1. Pratt LA, Brody DJ. Depression in the U.S. Household Population, 2009 – 2012. NCHS Data Brief. 2014;(172):2009–12. - PubMed
    1. Segall-Gutierrez P, Berman CS, Opper N, Dossett E, Moore K, Martin C, et al. The incidence of depression by fertility status in overweight and obese Latina women. J Immigr Minor Heal. 2012;14(6):1040–4. - PubMed
    1. Crawford NM, Hoff HS, Mersereau JE. Infertile women who screen positive for depression are less likely to initiate fertility treatments. Hum Reprod. 2017;32(3):582–7. - PMC - PubMed
    1. Cesta CE, Viktorin A, Olsson H, Johansson V, Sjölander A, Bergh C, et al. Depression, anxiety, and antidepressant treatment in women: association with in vitro fertilization outcome. Fertil Steril. 2016;105(6):1594–1602.e3. - PubMed
    1. Holley SR, Pasch LA, Bleil ME, Gregorich S, Katz PK, Adler NE. Prevalence and predictors of major depressive disorder for fertility treatment patients and their partners. Fertil Steril. 2015;103(5):1332–9. - PMC - PubMed

Publication types

MeSH terms

Substances

Associated data